The NFX Podcast
We believe creating something of true significance starts with seeing things others do not. NFX is a venture firm exclusively focused on pre-seed & seed stage startups.
The Past, Present, and Future of Longevity w/ Joe Betts-LaCroix Alex Colville
In this episode, Omri Amirav-Drory (NFX), Joe Betts-LaCroix (Retro Bio), and Alex Colville (Age1) discuss the history, recent progress, and hurdles in the longevity industry, including the evaluation of potential founders and business risks. The discussion further encompasses the global fundraising potential and societal impact of the longevity sector, viewing aging as a disease, and the future of longevity drugs. Learn more at - https://nfx.com/bio
Key Points
- Longevity is about transitioning from sick care to health care by addressing the root cause of most diseases, which is aging, with the mission of adding healthy years to human lifespan.
- The scientific history of longevity has evolved from early studies of calorie restriction and telomere biology to the identification of longevity genes, with current advancements focusing on cell therapy and biological pathways that slow or reverse aging.
- Investing in longevity is seen as a massive market opportunity due to the universal desire for health and increased lifespan, and the field is expected to have profound societal impacts, such as extended productive years and reduced age-related suffering.
Chapters
| 0:00 | |
| 4:21 | |
| 8:16 | |
| 12:15 | |
| 20:02 | |
| 22:08 | |
| 23:46 | |
| 27:24 | |
| 32:34 | |
| 36:08 | |
| 38:04 |
Transcript
Loading transcript...
- / -